News | November 28, 2025
Piramal Pharma Solutions achieves global nitrosamine compliance, strengthening patient safety
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
Silica is a proven and highly effective anti-caking agent that has been used for decades
Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
The company will also share results in two additional posters for deuruxolitinib
Subscribe To Our Newsletter & Stay Updated
